Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
NYU Langone Health
The goal of the Anxiety and COPD Evaluation (ACE) study is to validate the AIR scale by employing the Mini International Neuropsychiatric Interview to identify anxiety in 200 patients recruited at participating centers from the American Lung Association (ALA) Airways Research Network.
Confidential, not
Age
40–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Post-bronchodilation FEV1 \< 80% of the predictive normal value and FEV1 (forced expiratory volume in one second) / Forced vital capacity(FVC) ratio \< 0.7
Clinically stable COPD as defined by stable maintenance of COPD medications and absence of an exacerbation of symptoms requiring treatment with an antibiotic or corticosteroids
You may not be if
Exacerbation of respiratory symptoms in the past six weeks that resulted in the need for treatment or hospitalization
Unstable coronary heart disease such as recent myocardial infarction (within 3 months), untreated arrhythmia, or unstable angina
Major psychiatric disorders (except for depression and anxiety disorders) such as schizophrenia, schizoaffective, or other disorders that in the opinion of the study physician that would affect study participation
Montreal Cognitive Assessment (MoCA) \< 18
Disease or condition expected to cause death within six months or inability to perform study procedures, as judged by study physician
